GERMANTOWN – Governor Jim Doyle today broke ground on a major expansion of Cambridge Major Laboratories, Inc., a leading pharmaceutical research and development company.
“Cambridge Major Laboratories represents the future of Wisconsin – engaging the state’s brightest minds and exporting high-quality products across the world to advance critical medical technology,” Governor Doyle said. “Today’s expansion provides a major boost to Wisconsin’s world-renowned leadership in biotechnology research and development.”
Cambridge Major is one of the United States’ premier research and development firms, supplying advanced scientific services to biotech and pharmaceutical producers around the world. The $40 million expansion project, scheduled to be completed in August 2009, will more than triple its size to provide researchers with cutting-edge facilities and create 50 new high-end jobs.
Governor Doyle has set ambitious goals for Wisconsin to capture 10 percent of the market for biotechnology and stem cell research by 2015. To reach these goals, Governor Doyle launched a $750 million initiative to develop stem cell research and biotechnology in Wisconsin. Last month, Governor Doyle broke ground on the $150 million Institutes for Discovery, a public-private partnership to advance biological and medical research and the development of life-saving technologies.
As part of the next phase of his Grow Wisconsin agenda, Governor Doyle will continue to advance his plan to Innovate Wisconsin. The Governor proposes to accelerate groundbreaking research in the state by rewarding companies that significantly expand their research and development.
– 30 –
